Classical Hodgkin's Lymphoma

Also known as: Classical Hodgkin Lymphoma / Hodgkin Disease / Hodgkin's disease / Hodgkin's disease NOS / Hodgkin's granuloma / Hodgkin's paragranuloma / Hodgkin's sarcoma / Hodgkin's disease, unspecified type / Hodgins / Hodgkin lymphoma / Lymphomas Hodgkin's disease / Hodgkin's lymphoma / Lymphogranulomatosis

DrugDrug NameDrug Description
DB09035NivolumabA PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma.
DrugDrug NamePhaseStatusCount
DB09037Pembrolizumab0Recruiting1
DB08870Brentuximab vedotin1Withdrawn1
DB15770Cosibelimab1Recruiting1
DB09037Pembrolizumab1Recruiting2
DB09037Pembrolizumab1Terminated1
DB11836Sapanisertib1Withdrawn1
DB15295Tenalisib1Terminated1
DB11815Tilarginine1Recruiting1
DB06769Bendamustine1 / 2Active Not Recruiting1
DB08870Brentuximab vedotin1 / 2Completed1
DB00515Cisplatin1 / 2Completed1
DB00987Cytarabine1 / 2Completed1
DB00773Etoposide1 / 2Completed1
DB01590Everolimus1 / 2Recruiting1
DB00441Gemcitabine1 / 2Active Not Recruiting1
DB12154Itacitinib1 / 2Recruiting1
DB00959Methylprednisolone1 / 2Completed1
DB09035Nivolumab1 / 2Active Not Recruiting1
DB09035Nivolumab1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Recruiting1
DB00877Sirolimus1 / 2Recruiting1
DB06769Bendamustine2Completed1
DB06769Bendamustine2Not Yet Recruiting1
DB00290Bleomycin2Not Yet Recruiting1
DB00290Bleomycin2Recruiting1
DB08870Brentuximab vedotin2Recruiting2
DB14776Camrelizumab2Recruiting1
DB00531Cyclophosphamide2Not Yet Recruiting1
DB00531Cyclophosphamide2Recruiting1
DB00851Dacarbazine2Active Not Recruiting2
DB00851Dacarbazine2Not Yet Recruiting1
DB00851Dacarbazine2Recruiting3
DB00997Doxorubicin2Active Not Recruiting2
DB00997Doxorubicin2Completed1
DB00997Doxorubicin2Not Yet Recruiting1
DB00997Doxorubicin2Recruiting3
DB00445Epirubicin2Recruiting1
DB00773Etoposide2Not Yet Recruiting1
DB00441Gemcitabine2Recruiting1
DB09053Ibrutinib2Active Not Recruiting1
DB09053Ibrutinib2Recruiting1
DB03366Imidazole2Active Not Recruiting1
DB03366Imidazole2Recruiting1
DB06132Nivolumab2Active Not Recruiting1
DB09035Nivolumab2Active Not Recruiting2
DB06603Panobinostat2Completed1
DB09037Pembrolizumab2Active Not Recruiting1
DB09037Pembrolizumab2Not Yet Recruiting3
DB09037Pembrolizumab2Recruiting1
DB00635Prednisone2Completed1
DB00635Prednisone2Not Yet Recruiting1
DB01168Procarbazine2Not Yet Recruiting1
DB14922Tislelizumab2Completed1
DB14922Tislelizumab2Not Yet Recruiting1
DB14922Tislelizumab2Recruiting1
DB00570Vinblastine2Active Not Recruiting2
DB00570Vinblastine2Completed1
DB00570Vinblastine2Not Yet Recruiting1
DB00570Vinblastine2Recruiting2
DB00541Vincristine2Not Yet Recruiting1
DB00541Vincristine2Recruiting1
DB00361Vinorelbine2Recruiting1
DB00290Bleomycin3Recruiting1
DB08870Brentuximab vedotin3Recruiting1
DB14776Camrelizumab3Recruiting1
DB00531Cyclophosphamide3Active Not Recruiting1
DB00531Cyclophosphamide3Recruiting1
DB00851Dacarbazine3Active Not Recruiting1
DB00851Dacarbazine3Recruiting1
DB01234Dexamethasone3Recruiting1
DB00997Doxorubicin3Recruiting1
DB00773Etoposide3Recruiting1
DB00635Prednisone3Active Not Recruiting1
DB00635Prednisone3Recruiting1
DB01168Procarbazine3Recruiting1
DB14922Tislelizumab3Recruiting1
DB00541Vincristine3Active Not Recruiting1
DB00541Vincristine3Recruiting1